LabEx MAbImprove
FR
EN
Intranet
Contact us
Rechercher
OK
Ouvrir ou fermer la navigation
Home
The LabEx
Who we are?
Teams/Research groups
Platforms
Governance
Industrial workshops
Past events
Research
Presentation
KQ1 – How can target activity be modulated through antibody binding?
KQ2 – How can antibody activity be optimised by adjusting format?
KQ3 – How can antibody efficacy be increased using combinations?
KQ4 – How can antibody administration be improved?
CDI1 – Interdisciplinary innovation
CDI2 – Bio-clinical interface
Training
MAbInnovation
MAbBoost
Licensing
Health
Teaching tools
Clinical
Socioeconomic
Nomenclature
News
FR
EN
Intranet
Contact us
News
Events
10/04/2024
ANTIBODY INDUSTRIAL SYMPOSIUM 2024
Read more
News
10/04/2024
EUROMABNET 7TH ANTIBODY VALIDATION WORKSHOP AND 13TH MEETING
Read more
Recruitment
30/01/2024
MSCA Doctoral Network Acinetwork Phd Positions
Read more
View all news
Recherche et Formation
Training
KQ1
How can target activity be modulated through antibody binding?
KQ2
How can antibody activity be optimised by adjusting format?
KQ3
How can antibody efficacy be increased using combinations?
KQ4
How can antibody administration be improved?
CDI 1
Interdisciplinary innovation
CDI 2
Bio-clinical interface
Read more
Read more
Read more
Read more
Read more
Read more
Read more
Training
KQ1
How can target activity be modulated through antibody binding?
KQ2
How can antibody activity be optimised by adjusting format?
KQ3
How can antibody efficacy be increased using combinations?
KQ4
How can antibody administration be improved?
CDI 1
Interdisciplinary innovation
CDI 2
Bio-clinical interface